News

A new paper in Diabetologia does not support the hypothesis that exposure to viral infection in the first year of life may trigger beta cell autoimmunity and type 1 diabetes. Instead, the study finds that it...

Depression is more common in those diagnosed with type 2 diabetes under the age of 40 than those diagnosed later in life. These findings from UK and USA data, reported in a recent issue of Diabetologia, high...

The importance of maintaining normal glycaemia in type 2 diabetes from the day of diagnosis was underlined by the presentation of long-term findings from the UK Prospective Diabetes Study (UKPDS) at EASD 202...

A new study reported in a recent issue of Diabetologia identifies children in the general population in Germany who have presymptomatic type 1 diabetes and estimates their risk of going on to develop clinica...

As rates of type 2 diabetes continue to rise around the world, prevention of the condition has never been more important. A review in a recent issue of Diabetologia looks at the opportunities and challenges ...

SGLT-2 inhibitors are now recommended as first-line therapy for people with type 2 diabetes who have had a previous cardiovascular event. However, there are concerns over a few safety issues associated with ...

Modern lifestyles tend to preclude a prolonged fast during the night, with food being consumed over a long time period, which may have a detrimental effect on metabolic health. A new study, reported in a rec...

A new review, reported in a recent issue of Diabetologia, looks at glycaemic thresholds for the appearance of the signs and symptoms of hypoglycaemia in people with and without type 1 diabetes. These appear ...

Previous research has shown that both type 1 and type 2 diabetes are associated with increased morbidity and mortality from COVID-19 infection. However, we don’t know if this increased risk arises from...

Revealing the transcriptome of each pancreatic islet cell type could take us a long way towards clarifying the underlying mechanisms of type 2 diabetes. Single-cell RNA sequencing offers this level of geneti...

Obstructive sleep apnoea, with its various health consequences, is more common among people with type 2 diabetes than those without the condition. A new study, reported in a recent issue of Diabetologia, fin...

A new study in a recent issue of Diabetologia compares intermittent (flash) glucose monitoring with finger-prick testing in a group of pregnant women with type 1 diabetes. While flash did improve glycaemic c...

Tirzepatide is a new class of drug for management of type 2 diabetes. A meta-analysis of its glucose-lowering and weight-loss effects, presented in a recent issue of Diabetologia, will help guide treatment d...

A new analysis of the Global Burden of Disease study, presented in a recent issue of Diabetologia, reveals the geographical variation of type 2 diabetes and how risk factors for the associated morbidity and ...

Insulin allergy can cause significant challenges in diabetes treatment. A new paper in Diabetologia discusses the diagnosis and management of this rare, but important, condition. Dr Susan Aldridge reports.

A new analysis from the Adolescent Cardio-Renal Intervention Trial, reported in a recent issue of Diabetologia, shows that higher urinary albumin/creatinine ratio – even within the normal range –...

A new study, reported in a recent issue of Diabetologia, shows that dapagliflozin benefits people across a wide range of kidney disease severity. The findings, based on an analysis of the DAPA-CKD trial, tak...

Combining data from continuous glucose monitoring with self-care and mental health data could help improve diabetes care. A new review in Diabetologia looks at the emerging area of precision monitoring. Dr S...

Recent research suggests that pharmacoepigenetics may have clinical relevance in type 2 diabetes, from predicting who will respond to diabetes drugs to developing innovative therapies targeting epigenetic en...

Steroids, antipsychotics, antiretroviral therapy for HIV and immune checkpoint inhibitors against cancer: all of these may cause diabetes. A new review in Diabetologia looks at these four classes of diabetog...

If you’ve been following our Insulin in my country series, you might be interested in a commentary on the insulin market – past, present and future – which appears in a recent issue of Diab...